BKYI BIO key International Inc

BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2023 investor call Tuesday, April 2nd at 10 a.m. ET. Results will be released after the market close on Monday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session.

Conference Call Details

Date / Time:	Tuesday, April 2nd at 10 a.m. ET
Call Dial In #:	1-877-418-5460 U.S. or 1-412-717-9594 Int’l
Live Webcast / Replay:	Webcast & Replay Link – Available for 3 months.
Audio Replay:	1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6114035

BIO-key at a Glance

Recent Price	$2.00		TTM Revenue	$8.6M
Shares Out.*	1.9M		TTM Revenue Growth	+39%
Market Cap	$3.9M		Price/TTM Revenue	0.45X

* Common stock and common stock equivalents outstanding.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 38 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key

Facebook – Corporate:	https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate:	https://www.linkedin.com/company/bio-key-international
Twitter – Corporate:	@BIOkeyIntl
Twitter – Investors:	@BIO_keyIR
StockTwits:	BIO_keyIR

Investor Contacts

William Jones, David CollinsCatalyst IRBKYI@catalyst-ir.com212-924-9800